Skip to content
10-Q

Quarterly Report

Odonate Therapeutics, Inc.

0001564590-21-038065

← back to feed
Filed
Jul 27, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Jul 22, 2021 38.5M sh
Stock Issued Q2 2021 · Jun 30, 2021 842.11K sh
Stock Issued Q2 2021 · Sep 1, 2020 5.61M sh
Capex Q2 2021 · Jun 30, 2021 $26K
Capex Q2 2021 · Jun 30, 2020 $219K
Operating Cash Flow Q2 2021 · Jun 30, 2021 −$47.94M
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$56.48M
Cash And Equivalents Q2 2021 · Jun 30, 2021 $110.84M
Cash And Equivalents Q2 2021 · Dec 31, 2020 $157.98M
Cash And Equivalents Q2 2021 · Jun 30, 2020 $126.13M
Cash And Equivalents Q2 2021 · Dec 31, 2019 $181.17M
Stockholders Equity Q2 2021 · Jun 30, 2021 $84.63M
Stockholders Equity Q2 2021 · Mar 31, 2021 $105.3M
Stockholders Equity Q2 2021 · Dec 31, 2020 $136.15M
Stockholders Equity Q2 2021 · Jun 30, 2020 $105.55M
Stockholders Equity Q2 2021 · Mar 31, 2020 $135.24M
Stockholders Equity Q2 2021 · Dec 31, 2019 $162.3M
Current Liabilities Q2 2021 · Jun 30, 2021 $29.65M
Current Liabilities Q2 2021 · Dec 31, 2020 $27.07M
Total Liabilities Q2 2021 · Jun 30, 2021 $33.95M
Total Liabilities Q2 2021 · Dec 31, 2020 $31.74M
Current Assets Q2 2021 · Jun 30, 2021 $112.07M
Current Assets Q2 2021 · Dec 31, 2020 $159.87M
Total Assets Q2 2021 · Jun 30, 2021 $118.57M
Total Assets Q2 2021 · Dec 31, 2020 $167.89M
Sga Expense Q2 2021 · Jun 30, 2021 $3.43M
Sga Expense Q2 2021 · Jun 30, 2021 $6.32M
Sga Expense Q2 2021 · Jun 30, 2020 $2.75M
Sga Expense Q2 2021 · Jun 30, 2020 $5.63M
Rd Expense Q2 2021 · Jun 30, 2021 $18.63M
Rd Expense Q2 2021 · Jun 30, 2021 $49.55M
Rd Expense Q2 2021 · Jun 30, 2020 $30.78M
Rd Expense Q2 2021 · Jun 30, 2020 $58.72M
Net Income Q2 2021 · Jun 30, 2021 −$22.02M
Net Income Q2 2021 · Jun 30, 2021 −$55.78M
Net Income Q2 2021 · Mar 31, 2021 −$33.77M
Net Income Q2 2021 · Jun 30, 2020 −$33.42M
Net Income Q2 2021 · Jun 30, 2020 −$63.59M
Net Income Q2 2021 · Mar 31, 2020 −$30.16M
Operating Income Q2 2021 · Jun 30, 2021 −$22.05M
Operating Income Q2 2021 · Jun 30, 2021 −$55.87M
Operating Income Q2 2021 · Jun 30, 2020 −$33.53M
Operating Income Q2 2021 · Jun 30, 2020 −$64.35M